The 6 references without contexts in paper R. Yagudina I., A. Kulikov U., V. Babiy V., E. Arinina E., Р. Ягудина И., А. Куликов Ю., В. Бабий В., Е. Аринина Е. (2018) “Фармакоэкономика ВИЧ-инфекции // Pharmacoeconomics of HIV-infection” / spz:neicon:vedomostincesmp:y:2015:i:4:p:58-63

4
Kulikov AYu., Litvinenko MM. Methodological basics of modeling in the pharmacoeconomic studies: different levels of complexity and different value of the results obtained. Farmakoekonomika: teoriya i praktika 2014; 2(2): 9–22 (in Russian).
(check this in PDF content)
10
Habriev RU, Kulikov AYu, Arinina EE. Methodological basics of pharmacoeconomic analysis. M.: Meditsina; 2011 (in Russian).
(check this in PDF content)
11
Yagudina RI, Babiy VV. Methodological basics of effectiveness analysis of health technologies in pharmacoeconomic studies. Farmakoekonomika: teoriya i praktika 2015; 3(1): 7–16 (in Russian).
(check this in PDF content)
12
Yagudina RI, Habriev RU, Pravdyuk NG. Health technologies assessment. M.: Meditsinskoe informatsionnoe agenstvo; 2013 (in Russian).
(check this in PDF content)
15
Easterbrook PJ, et al. The role of mathematical modeling in the development of recommendations in the 2013 WHO consolidated antiretroviral therapy guidelines. AIDS 2014; 28(1): 85–92.
(check this in PDF content)
16
Nakagawa F, May M, Philips A. Life expectancy living with HIV: recent estimates and future implications. Current Opinion in Infectious Diseases 2013; 26(1): 17–25.
(check this in PDF content)